Intelligent Bio Solutions Announces 1-For-10 Reverse Split, Effective December 15

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("Intelligent Bio Solutions" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective at 11:59 pm (Eastern Time) on December 15, 2025. Trading of the Company's common stock on The Nasdaq Capital Market ("Nasdaq") will continue, on a split-adjusted basis, with the opening of the markets on December 16, 2025, under the trading symbol "INBS" and new CUSIP number 36151G709.